Standard Biotools Inc traded at $1.75 this Tuesday June 28th, decreasing $0.06 or 3.06 percent since the previous trading session. Looking back, over the last four weeks, Standard Biotools Inc lost 7.67 percent. Over the last 12 months, its price fell by 72.52 percent. Looking ahead, we forecast Standard Biotools Inc to be priced at 1.70 by the end of this quarter and at 1.57 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
1.75
Daily Change
-3.06%
Yearly
-72.52%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Sony 11,600.00 95.00 0.83% 5.45%
Nikon Corporation 1,643.00 16.00 0.98% 37.72%
Agilent 118.73 -1.84 -1.53% -20.21%
Becton, Dickinson and Co. 248.27 -1.83 -0.73% 0.56%
Bio-Rad Laboratories 501.01 -6.68 -1.32% -22.39%
Bruker 65.02 1.19 1.86% -14.44%
Danaher 253.52 -2.89 -1.13% -6.41%
Standard Biotools Inc 1.75 -0.06 -3.06% -72.52%
Illumina 191.24 -2.11 -1.09% -60.09%
Myriad Genetics 18.65 -0.24 -1.27% -38.79%
NanoString Technologies 13.42 -0.16 -1.18% -80.33%
Pacific Biosciences Of California 5.00 -0.32 -5.93% -86.13%
PerkinElmer 142.99 -1.98 -1.37% -8.25%
Roche Holding 317.55 -5.00 -1.55% -8.96%
Thermo Fisher Scientific 541.59 -2.05 -0.38% 6.56%
Waters 330.79 0.55 0.17% -4.16%

Indexes Price Day Year
USND 11322 -202.64 -1.76% -22.07%
US2000 1762 -9.52 -0.54% -23.67%

Standard Biotools Inc
Fluidigm Corporation creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents, and software that are used by researchers and clinical labs. The Company operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. It markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.